Quantum BioPharma Ltd. - QNTM Market Valuation

Official company branding of Quantum BioPharma Corp (QNTM)

The asset value of Quantum BioPharma Ltd (QNTM) tracked on the GURU.Markets chart is 0.02. The business relies on the development of diverse pharmaceuticals. High testing costs and patent protection create significant barriers to entry, while FDA oversight tightens regulations. A lack of recurring revenue necessitates the attraction of external investment. Meanwhile, formula customization and a broad portfolio allow the company to avoid direct price wars.

QNTM Quantum BioPharma: Market Valuation in the range 08/16/2024 - 11/11/2026

Comprehensive metric breakdowns and analytics for Quantum BioPharma Corp (QNTM)

- market price and analyst price targets:
Fundamental company analysis:QNTM (Quantum BioPharma)
Product sample of Quantum BioPharma Corp

The stability of raw material supply chains at Quantum BioPharma Ltd (QNTM) creates a foundation for sustainable business growth. An analysis of the company's current market capitalization allows for an assessment of the market value of all outstanding shares. This indicator is calculated as the product of the price of a single security and the total number of shares outstanding. This metric determines the scale of the enterprise relative to competitors in the biopharmaceutical sector, helping investors avoid overpaying for the asset at the peak of the cycle.

Key competitors

Market Value Haleon HLN|KVUE: Market Capitalization|VRNA: Market Valuation|Jyong Bio - Market Value|Ligand Pharmaceuticals (LGND) - Market Value|Market Valuation amneal.com|Market Value Perrigo|Alvotech S.A. - Market Valuation|Market Capitalization LQDA|GLPG (Galapagos Corp) - Market Value|Market Capitalization ANIP (ANI Pharmaceuticals)|Market Capitalization mannkindcorp.com MNKD|AMPH - Market Value|Market Value PCRX (Pacira Pharmaceuticals)|ARS Pharma (SPRY) - Market Value|Market Valuation Theravance Corp|AQST (Aquestive Therapeutics) - Market Capitalization|Market Capitalization scPharma|Market Valuation TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharma) - Market Value|Market Value China SXT Pharmaceuticals, Inc. SXTC|Eupraxia Pharmaceuticals, Inc. (EPRX) - Market Value|BHST: Market Valuation|invizyne.com - Market Value|ORMP: Market Capitalization|Entera Bio - Market Value|HYFT (MindWalk) - Market Capitalization|Market Value ABVC BioPharma, Inc ABVC|Market Value Cumberland Pharmaceuticals (CPIX)|FGEN (fibrogen.com) - Market Value|Market Value Telomir Pharmaceuticals, Inc. TELO|Market Capitalization Rani Therapeutics Holdings|SNYR: Market Valuation|RLYB - Market Capitalization|LEXX: Market Capitalization|pulmatrix.com (PULM) - Market Capitalization|Market Value Pheton Holdings Limited|Market Capitalization APM (Aptorum)|Market Valuation LYRA (Lyra Therapeutics, Inc)|Market Value IBO|TNF Pharmaceuticals, Inc. - Market Valuation|Market Capitalization cbdMD Inc. YCBD|PRFX - Market Value|Altamira Therapeutics (CYTO) - Market Valuation|LIPO (Lipella) - Market Valuation|OptiNose Corp - Market Value|PIRS (Pieris Pharmaceuticals) - Market Capitalization|Market Value PROC|Market Capitalization PTPI|Market Capitalization Qilian International Holding Group|Market Value ACELYRIN, Inc. SLRN|TFF Pharmaceuticals, Inc (TFFP) - Market Value